NYXH
Price
$6.46
Change
+$0.02 (+0.31%)
Updated
Aug 25 closing price
Capitalization
249.7M
79 days until earnings call
PROF
Price
$4.67
Change
-$0.07 (-1.48%)
Updated
Aug 25 closing price
Capitalization
141.46M
65 days until earnings call
Interact to see
Advertisement

NYXH vs PROF

Header iconNYXH vs PROF Comparison
Open Charts NYXH vs PROFBanner chart's image
Nyxoah SA
Price$6.46
Change+$0.02 (+0.31%)
Volume$69K
Capitalization249.7M
Profound Medical
Price$4.67
Change-$0.07 (-1.48%)
Volume$36.45K
Capitalization141.46M
NYXH vs PROF Comparison Chart in %
Loading...
NYXH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PROF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NYXH vs. PROF commentary
Aug 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NYXH is a Buy and PROF is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 26, 2025
Stock price -- (NYXH: $6.45 vs. PROF: $4.67)
Brand notoriety: NYXH and PROF are both not notable
NYXH represents the Pharmaceuticals: Other, while PROF is part of the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: NYXH: 72% vs. PROF: 40%
Market capitalization -- NYXH: $249.7M vs. PROF: $141.46M
NYXH [@Pharmaceuticals: Other] is valued at $249.7M. PROF’s [@Medical/Nursing Services] market capitalization is $141.46M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $167.92B to $0. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $229.51B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $11.07B. The average market capitalization across the [@Medical/Nursing Services] industry is $5.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NYXH’s FA Score shows that 0 FA rating(s) are green whilePROF’s FA Score has 0 green FA rating(s).

  • NYXH’s FA Score: 0 green, 5 red.
  • PROF’s FA Score: 0 green, 5 red.
According to our system of comparison, PROF is a better buy in the long-term than NYXH.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NYXH’s TA Score shows that 4 TA indicator(s) are bullish while PROF’s TA Score has 4 bullish TA indicator(s).

  • NYXH’s TA Score: 4 bullish, 5 bearish.
  • PROF’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, NYXH is a better buy in the short-term than PROF.

Price Growth

NYXH (@Pharmaceuticals: Other) experienced а -1.75% price change this week, while PROF (@Medical/Nursing Services) price change was -1.68% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +3.61%. For the same industry, the average monthly price growth was +2.14%, and the average quarterly price growth was +19.48%.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +1.30%. For the same industry, the average monthly price growth was +2.22%, and the average quarterly price growth was +7.63%.

Reported Earning Dates

NYXH is expected to report earnings on Nov 13, 2025.

PROF is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+3.61% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

@Medical/Nursing Services (+1.30% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NYXH($250M) has a higher market cap than PROF($141M). NYXH YTD gains are higher at: -19.313 vs. PROF (-37.816). PROF has higher annual earnings (EBITDA): -41.56M vs. NYXH (-64.3M). NYXH has more cash in the bank: 63M vs. PROF (35.2M). PROF has less debt than NYXH: PROF (4.81M) vs NYXH (22.1M). PROF has higher revenues than NYXH: PROF (11.8M) vs NYXH (4.36M).
NYXHPROFNYXH / PROF
Capitalization250M141M177%
EBITDA-64.3M-41.56M155%
Gain YTD-19.313-37.81651%
P/E RatioN/AN/A-
Revenue4.36M11.8M37%
Total Cash63M35.2M179%
Total Debt22.1M4.81M459%
FUNDAMENTALS RATINGS
PROF: Fundamental Ratings
PROF
OUTLOOK RATING
1..100
82
VALUATION
overvalued / fair valued / undervalued
1..100
47
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
88
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
NYXHPROF
RSI
ODDS (%)
Bullish Trend 1 day ago
75%
Bullish Trend 1 day ago
85%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
67%
Bullish Trend 1 day ago
78%
Momentum
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
86%
MACD
ODDS (%)
Bearish Trend 5 days ago
86%
Bearish Trend 1 day ago
85%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
84%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
86%
Advances
ODDS (%)
Bullish Trend 1 day ago
73%
Bullish Trend 27 days ago
74%
Declines
ODDS (%)
Bearish Trend 14 days ago
89%
Bearish Trend 14 days ago
83%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
73%
Bullish Trend 1 day ago
82%
Aroon
ODDS (%)
N/A
Bearish Trend 1 day ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
NYXH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PROF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KCDMF1.90N/A
N/A
Kimberly-Clark de Mexico, S.A.B de C.V.
MPGPF3.76N/A
N/A
PageGroup PLC
BYLB92.00N/A
N/A
Boyle Bancorp, Inc.
NWRV0.01N/A
N/A
Nationwide RV and Resorts, Inc.
LGRDY30.16-0.66
-2.14%
LeGrand SA

PROF and

Correlation & Price change

A.I.dvisor tells us that PROF and LZAGY have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PROF and LZAGY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PROF
1D Price
Change %
PROF100%
-1.48%
LZAGY - PROF
29%
Poorly correlated
+0.21%
MTD - PROF
28%
Poorly correlated
-2.40%
A - PROF
26%
Poorly correlated
-2.04%
NYXH - PROF
25%
Poorly correlated
+0.39%
IQV - PROF
24%
Poorly correlated
-1.64%
More